1. 1428PTesting for and frequency of molecular alterations in patients with advanced NSCLC in Germany. Results from the prospective German registry CRISP (AIO-TRK-0315). (23rd October 2018) Authors: Griesinger, F; Eberhardt, W E E; Nusch, A; Reiser, M; Bernhardt, C; Marschner, N; Jaenicke, M; Fleitz, A; Spring, L; Sahlmann, J; Karatas, A; Hipper, A; Weichert, W; Rittmeyer, A; Bischoff, H; Waller, C; Thomas, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1432PHybrid capture NGS reliably detects a spectrum of clinically significant genetic aberrations in both, primary diagnostics and the relapse scenario. (23rd October 2018) Authors: Schatz, S; Falk, M; Menon, R; Heukamp, L C; Roeper, J; Griesinger, F; Tiemann, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1447PRisk of not receiving second-line therapy is high in EGFR mt+ pts: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ pts. (23rd October 2018) Authors: Roeper, J; Falk, M; Schatz, S; Tiemann, M; Wesseler, C; Wiest, G; Sackmann, S; Ukena, D; Heukamp, L C; Griesinger, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1449PEfficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany. (23rd October 2018) Authors: Brueckl, W M; Laack, E; Reck, M; Griesinger, F; Schäfer, H; Kortsik, C; Gaska, T; Rawluk, J; Krüger, S; Kokowski, K; Budweiser, S; Schueler, A; Kiessling, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 493OTepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data. (25th November 2018) Authors: Sakai, H; Felip, E; Cortot, A B; Veillon, R; Griesinger, F; Patel, J; Horn, L; Mazieres, J; De Castro Carpeno, J; Morise, M; Sakamoto, T; Bruns, R; Scheele, J; Straub, J; Paik, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study. (14th April 2018) Authors: Novello, S; Mazières, J; Oh, I -J; de Castro, J; Migliorino, M R; Helland, Å; Dziadziuszko, R; Griesinger, F; Kotb, A; Zeaiter, A; Cardona, A; Balas, B; Johannsdottir, H K; Das-Gupta, A; Wolf, J Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LBA1Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial. (24th November 2019) Authors: Camidge, R; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; Califano, R; Spira, A; Gettinger, S; Tiseo, M; Ni, Q; Zhang, P; Popat, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LBA58Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. (23rd October 2018) Authors: Popat, S; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; Califano, R; Spira, A I; Gettinger, S; Tiseo, M; Haney, J; Kerstein, D; Camidge, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗